Oral surgery is a high-margin, procedure-dependent dental specialty with strong consolidation interest from PE firms, DSOs (dental service organizations), and larger oral surgery groups. Understanding your practice's value requires translating procedure volume, referral diversification, and associate strength into EBITDA metrics that buyers price.

Start with EBITDA. Oral surgery practice EBITDA is revenue (surgical procedure fees—typically $150-400 per extraction, $400-1,200+ per implant, $300-800 per other procedures, times monthly volume) minus surgical staff (assistants, hygienists, administrative), minus supplies (sterile instruments, bone grafting materials, implants), minus facility costs (rent, utilities, insurance), minus continuing education and licensing. Owner compensation treatment: if owner is actively performing surgeries, separate surgical compensation (what you'd pay an associate surgeon—typically $150-200K depending on region and experience) from practice management (typically $60-100K). Add back only non-surgical salary above market.

Multiples range 5x-9x EBITDA depending on the six drivers. Premium multiples (8x-9x) require 300+ monthly procedures, 50+ diverse referring dentists, 30%+ implant mix, associate surgeon(s) in place, IV sedation/GA capability, and modern facilities. Practices with 200-250 monthly cases and fewer associates trade at 5x-6x. Understanding where your practice sits is critical.

Procedure volume is the revenue foundation. Oral surgery revenue is entirely procedure-driven. Calculate 24-month average monthly procedure count and break down by type (extractions, implants, impactions, other). Growing volume (3-5% annually) signals healthy referral flow; declining volume signals referral loss or market pressure. Volume stability matters: stable 300-case months are more valuable than volatile 200-400 swings because buyer cash flow projections are more predictable.

Referral relationship diversification is the valuation linchpin. Practices where 30%+ of volume comes from 1-3 referring dentists face buyer relationship loss risk. Ideal diversification: 50+ active referring dentists with no single >10% of volume. Walk through your referral list monthly for past 24 months. If concentrated, referral development (recruiting new general dentistry referrers, developing relationships with dental schools or group practices) 12-18 months before sale is highest-impact initiative. Diversification can add 0.5-1.0x EBITDA multiple expansion.

Implant program strength is margin driver. Extraction cases ($150-300 fee) are commodity pricing. Implant cases ($400-1,200+ fee, especially complex bone grafts or sinus lifts) have much higher margins. Calculate case mix: what percentage implants vs extractions? If implants are <20% of volume, consider recruitment and case selection optimization. Implant-focused practices (30%+ mix) command 0.5-1x EBITDA premium because margins are higher and buyer growth projection is stronger.

Associate surgeon presence is acquisition-critical. Owner-only practices face succession risk and buyer operational concerns. Practices with one or more employed associate surgeons enable weekday coverage, case distribution, and scaling. Associates with 2+ year tenure and established patient relationships (evidenced by case volume per associate) are retained assets. If you're currently owner-only, recruiting an associate 18-24 months before sale is a major valuation driver (adds 0.5-1x EBITDA multiple by reducing owner dependency).

Anesthesia capability enables complex case handling. Practices with IV sedation and general anesthesia (with appropriate training and credentials) can manage anxious patients and complex procedures, supporting higher case volume and fees. Practices limited to local anesthesia face volume and complexity ceilings. If you don't have IV sedation capability, investing in training and credentialing (cost $5-15K) 12-18 months before sale adds capability signaling and buyer confidence.

Facility modernization signals operational readiness. CBCT imaging (cone beam CT), digital radiography, intraoral cameras, and modern sterilization systems enable case complexity and speed. Outdated equipment (paper records, older radiography, manual sterilization) limits case types and buyer confidence. Equipment evaluation: is imaging modern? Sterilization system adequate? Surgical suite layout optimized for efficiency? Modernization can add 0.2-0.3x EBITDA premium through operational efficiency signal.

Work with a dental-specialized M&A advisor (DSO broker or dental healthcare consultant) 12-18 months before intended sale. They'll assess your referral diversification, implant program strength, and associate depth. Common pre-sale moves: recruiting associate surgeon, developing implant program, or diversifying referral base. These moves cost $50-150K but add $300K-$600K+ in enterprise value through multiple expansion and operational maturity. DSO (dental service organization) vs independent sale creates different buyer dynamics. DSOs (Aspen, Heartland, Great Expressions, others) pay for growth platforms and margin expansion opportunity. Practices with high implant growth trajectory and strong referral diversification command premiums from DSO buyers. Regional oral surgery consolidators pay for market share and case volume. Understanding buyer pool and timing sale during active DSO acquisition cycles improves valuation.